New database lets marketers make house calls to docs

Share this article:

Healthcare Data Solutions (HDS) launched a new database providing home addresses and personal email account listings for physicians, dentists, nurses and other healthcare providers.

The database, called PrescriberPRO@Home, includes 190,000 home email addresses that are CAN-SPAM compliant, and half a million postal addresses that have been validated by the USPS, according to a statement.

Chris Lundgren, VP of sales at HDS, said product development at the company is driven by customer requests, adding that healthcare recruiters and publications in particular have expressed a need for home addresses and personal email lists.

The new database also helps HDS keep their physicians' office data — the company's "bread and butter," according to Lundgren — current, since doctors aren't likely to file a national change of address when they switch practices or move to a new office, but they would if their home address changed.

Lundgren said personal email address are often captured when doctors sign up to attend events or receive services, and many of HDS's clients already have the information.  "We clean up and enhance our clients' customer files for them," Lundgren said, adding that many customer files HDS receives for sprucing already contain personal email accounts and home addresses.

The PrescriberPRO@Home database allows marketers to sort results based on practice name, group or hospital affiliation, license information, specialty and other categories, the statement said.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Judge blocks FDA bid to allow generic Precedex

Judge blocks FDA bid to allow generic Precedex

The US District Court for Maryland granted Hospira a temporary restraining order (TRO) against FDA, after the agency determined that potential generic competitors of the company's injectable sedation drug Precedex ...

GSK drug gets aplastic anemia indication

GSK drug gets aplastic anemia indication

Promacta was previously indicated for chronic immune thrombocytopenia.

Five things for Pharma Marketers to know: Wednesday, August 27

Five things for Pharma Marketers to know: Wednesday, ...

Allergan sets a shareholder voting date, Novo describes the types of acquisitions it will consider, and the AstraZeneca-Pfizer talks can now reopen.